Inhibition of receptor tyrosine kinase activity involved in the EGFR signalling cascade forms the basis for the use of EGFR specific tyrosine kinase inhibitors exemplified by gefitinib ZD1839, Iressa and erlotinib OSI 774, Tarceva priligy and viagra In certain embodiments, a method of the present application lowers NTX biomarker in a subject